These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
366 related items for PubMed ID: 25331843
1. Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension. Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Böhm M, Mahfoud F. Hypertension; 2015 Jan; 65(1):193-9. PubMed ID: 25331843 [Abstract] [Full Text] [Related]
2. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension. Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M. Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578 [Abstract] [Full Text] [Related]
3. Effect of Arteriovenous Anastomosis on Blood Pressure Reduction in Patients With Isolated Systolic Hypertension Compared With Combined Hypertension. Ott C, Lobo MD, Sobotka PA, Mahfoud F, Stanton A, Cockcroft J, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Saxena M, Scott B, Ng GA, Achenbach S, Schmieder RE. J Am Heart Assoc; 2016 Dec 21; 5(12):. PubMed ID: 28003251 [Abstract] [Full Text] [Related]
4. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Böhm M, SPYRAL HTN-OFF MED trial investigators*. Lancet; 2017 Nov 11; 390(10108):2160-2170. PubMed ID: 28859944 [Abstract] [Full Text] [Related]
5. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies. Fengler K, Rommel KP, Lapusca R, Blazek S, Besler C, Hartung P, von Roeder M, Kresoja KP, Desch S, Thiele H, Lurz P. Hypertension; 2019 Aug 11; 74(2):341-348. PubMed ID: 31203726 [Abstract] [Full Text] [Related]
6. Renal sympathetic denervation: early impact on ambulatory resistant hypertension. Schwerg M, Heupel C, Strajnic D, Baumann G, Laule M, Stangl V, Stangl K. J Clin Hypertens (Greenwich); 2014 Jun 11; 16(6):406-11. PubMed ID: 24766570 [Abstract] [Full Text] [Related]
7. Pulse Wave Velocity Predicts Response to Renal Denervation in Isolated Systolic Hypertension. Fengler K, Rommel KP, Hoellriegel R, Blazek S, Besler C, Desch S, Schuler G, Linke A, Lurz P. J Am Heart Assoc; 2017 May 17; 6(5):. PubMed ID: 28515119 [Abstract] [Full Text] [Related]
8. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension. Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B. Blood Press; 2014 Aug 17; 23(4):228-32. PubMed ID: 24432803 [Abstract] [Full Text] [Related]
9. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A. Hypertension; 2014 May 17; 63(5):991-9. PubMed ID: 24591332 [Abstract] [Full Text] [Related]
10. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial. Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, Schmieder RE, Janas AJ, Langer C, Persu A, Mendelsohn FO, Ameloot K, Foster M, Fischell TA, Parise H, Mahfoud F. Circulation; 2024 Jun 11; 149(24):1875-1884. PubMed ID: 38587557 [Abstract] [Full Text] [Related]
11. Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial. Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, Fisher NDL, Schmieder RE, Mahfoud F, Lindsey J, Sanghvi K, Todoran TM, Pacella J, Flack J, Daemen J, Sharp ASP, Lurz P, Bloch MJ, Weber MA, Lobo MD, Basile J, Claude L, Reeve-Stoffer H, McClure CK, Kirtane AJ, RADIANCE II Investigators and Collaborators. JAMA; 2023 Feb 28; 329(8):651-661. PubMed ID: 36853250 [Abstract] [Full Text] [Related]
12. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Böhm M. Eur Heart J; 2017 Jan 07; 38(2):93-100. PubMed ID: 28158510 [Abstract] [Full Text] [Related]
13. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension. Lambert T, Blessberger H, Gammer V, Nahler A, Grund M, Kerschner K, Buchmayr G, Saleh K, Kammler J, Steinwender C. Clin Cardiol; 2014 May 07; 37(5):307-11. PubMed ID: 24700288 [Abstract] [Full Text] [Related]
14. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry). Kądziela J, Prejbisz A, Kostka-Jeziorny K, Dudek D, Narkiewicz K, Sadowski J, Lekston A, Gziut A, Więcek A, Buszman P, Kleinrok A, Kochman J, Czarnecka D, Januszewicz A, Witkowski A. Kardiol Pol; 2016 May 07; 74(9):961-8. PubMed ID: 27160171 [Abstract] [Full Text] [Related]
15. Twenty-Four-Hour Blood Pressure Monitoring to Predict and Assess Impact of Renal Denervation: The DENERHTN Study (Renal Denervation for Hypertension). Gosse P, Cremer A, Pereira H, Bobrie G, Chatellier G, Chamontin B, Courand PY, Delsart P, Denolle T, Dourmap C, Ferrari E, Girerd X, Michel Halimi J, Herpin D, Lantelme P, Monge M, Mounier-Vehier C, Mourad JJ, Ormezzano O, Ribstein J, Rossignol P, Sapoval M, Vaïsse B, Zannad F, Azizi M. Hypertension; 2017 Mar 07; 69(3):494-500. PubMed ID: 28115517 [Abstract] [Full Text] [Related]
16. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension. Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M. Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238 [Abstract] [Full Text] [Related]
17. The effect of renal denervation on resistant hypertension: Meta-analysis of randomized controlled clinical trials. Yao Y, Zhang D, Qian J, Deng S, Huang Y, Huang J. Clin Exp Hypertens; 2016 Nov 30; 38(3):278-86. PubMed ID: 27018652 [Abstract] [Full Text] [Related]
18. Evaluation of the potential interaction between NaCl and prostaglandin inhibition in elderly individuals with isolated systolic hypertension. Alam S, Purdie DM, Johnson AG. J Hypertens; 1999 Aug 30; 17(8):1195-202. PubMed ID: 10466476 [Abstract] [Full Text] [Related]
19. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder RE, Tsioufis K, Pocock S, Dimitriadis K, Choi JW, East C, D'Souza R, Sharp ASP, Ewen S, Walton A, Hopper I, Brar S, McKenna P, Fahy M, Böhm M. Lancet; 2022 Apr 09; 399(10333):1401-1410. PubMed ID: 35390320 [Abstract] [Full Text] [Related]
20. First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G, GSR Investigators. Hypertension; 2015 Apr 09; 65(4):766-74. PubMed ID: 25691618 [Abstract] [Full Text] [Related] Page: [Next] [New Search]